Vytorin New Zealand - English - Medsafe (Medicines Safety Authority)

vytorin

merck sharp & dohme (new zealand) limited - ezetimibe 10mg; simvastatin 10mg - tablet - 10/10mg - active: ezetimibe 10mg simvastatin 10mg excipient: butylated hydroxyanisole citric acid monohydrate croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose propyl gallate - homozygous familial hypercholesterolaemia vytorin is indicated for the reduction of elevated total-c and ldl-c levels in adult and adolescent (10 to 17 years of age) patients with hofh. patients may also receive adjunctive treatments (e.g., ldl apheresis).